Clinico-epidemiological profile and treatment outcome of lip cancer: a retrospective study from north India

Tavseef Ahmad Tali; Fiza Amin; Nazir Ahmad Khan; Javaid Ahmad Dar; Mushtaq Ahmad Sofi

doi:10.18203/2320-6012.ijrms20231633

Authors

Tavseef Ahmad Tali Department of Radiation Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Fiza Amin Department of Gynaecology and Obstetrics, Skims Medical College and Hospital, Srinagar, Jammu and Kashmir, India
Nazir Ahmad Khan Department of Radiation Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Javaid Ahmad Dar Department of Cardiology, Christian Medical College, Vellore, Tamil Nadu, India
Mushtaq Ahmad Sofi Department of Radiation Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231633

Keywords:

Basal cell carcinoma, Lip cancer, Radiotherapy, Squamous cell carcinoma, Surgery

Abstract

Background: Aim of present study to evaluate the Clinico-epidemiological profile and treatment outcome of Lip Cancer.

Methods: This was a retrospective study performed in our hospital. All necessary clinical and epidemiological details of the 11 cases diagnosed with lip cancer from January 2016 to December 2021 were analysed.

Results: The total number of new malignant cases diagnosed as lip cancer between January 2016 and December 2021 were 11, which comprised 6 male (55%) and 5 (45%) female. The male-to-female ratio was (1.2:1). The most common histological type was SCC, i.e., in 9 (81.8%) of the total number of cases and BCC was in 2 patients (18.2%). Overall survival at 5 years was 89% in our study.

Conclusions: In conclusion, we have reported higher levels of lip cancer among men and those above 45 years of age. The important prognostic factors for overall survival in these patients were cancer stages. Better survival is achieved with surgery alone in the early stages and with adjuvant radiotherapy in the later stages.

Metrics

Metrics Loading ...

References

Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis. 1999;5(3):185-95.

De Visscher JG, Schaapveld M, Otter R, Visser O, Van der Waal I. Epidemiology of cancer of the lip in The Netherlands. Oral Oncol. 1998;34(5):421-6.

Luna-Ortiz K, Güemes-Meza A, Villavicencio-Valencia V, Mosqueda-Taylor A. Lip cancer experience in Mexico. An 11-year retrospective study. Oral Oncol. 2004;40(10):992-9.

Czerninski R, Zini A, Sgan‐Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970–2006. British J Dermatol. 2010;162(5):1103-9.

Zitsch RP, Lee BW, Smith RB: Cervical lymph node metastases and squamous cell carcinoma of the lip. Head Neck. 1999;21:447-53.

Khuder SA. Etiologic clues to lip cancer from epidemiologic studies on farmers. Scand J Work Environ Health. 1999;25:125-30.

Perea-Milla López E, Miñarro-Del Moral RM, Martínez-García C, Zanetti R, Rosso S, Serrano S, et al. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case–control study in southern Spain. Br J Cancer. 2003;88:1702-7.

Vartanian JG, Carvalho AL, de Araujo Filho MJ, Junior MH, Magrin J, Kowalski LP. Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck. Oral Oncol. 2004;40:223-7.

Morton RP, Missotten FE, Pharoah PO. Classifying cancer of the lip: an epidemiological perspective. Euro J Cancer Clin Oncol. 1983;19(7):875-9.

von Figura G, Hartmann D, Song Z, Rudolph KL. Role of telomere dysfunction in aging and its detection by biomarkers. J Mole Med. 2009;87:1165-71.

Capell BC, Tlougan BE, Orlow SJ. From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Invest Dermatol. 2009;129(10):2340-50.

Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes & Control. 1996;7(4):458-63.

Papadopoulos O, Konofaos P, Tsantoulas Z, Chrisostomidis C, Frangoulis M, Karakitsos P. Lip defects due to tumor excision: apropos of 899 cases. Oral Oncol. 2007;43(2):204-12.

Chi AC. Epithelial pathology-lip vermilion carcinoma. In: Oral and Maxillofacial Pathology. Neville BW, Damm DD, Allen CM, Bouquot JE (eds.). Philadelphia, Saunders; 2009:414-415.

Czerninski R, Zini A, Sgan‐Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970–2006. British J Dermato. 2010;162(5):1103-9.

Abreu L, Kruger E, Tennant M. Lip cancer in Western Australia, 1982–2006: a 25‐year retrospective epidemiological study. Austra Dental J. 2009;54(2):130-5.

Baker SR, Krause CJ. Carcinoma of the lip. The Laryngoscope. 1980;90(1):19-27.

Raskob GE, Zitsch III RP, Park CW, Renner GJ, Rea JR JL. Outcome analysis for lip carcinoma. Otolary–Head N Surg. 1995;113(5):589-96.

Cruse CW, Radocha RF. Squamous cell carcinoma of the lip. Plastic Reconstr Surg. 1987;80(6):787-91.

Luna-Ortiz K, Güemes-Meza A, Villavicencio-Valencia V, Mosqueda-Taylor A. Upper lip malignant neoplasms. A study of 59 cases. Medicina Oral, Patologia O Cirugia Bucal. 2012;17(3):e371.